Trial NCT03236649

View at ClinicalTrials.gov 
Org. Study IDs: SNG1705ICR-2

Last trial update was posted on 2023-02-08

MeSH Interventions

Sorafenib

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular

Other Conditions

Hepatocellular Carcinoma (HCC)

Stopping Reasons

Because the clinical development plan has been changed.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID